Almost each of these companies has a different technology to show for the effectiveness against microbes.
Testing only those with symptoms is not such a great idea. A lot of asymptomatic people are also positive. Its also important to do some amount of random testing in the clusters. You need to do lot more testing. The more you test, the more positives you get. Only redeeming feature is that the number of those getting into ICU or dying is not huge, she said.
More than 2 million people have been diagnosed with coronavirus across the world, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global pandemic. According to the World Health Organization, there are now more than 70 potential vaccines under evelopment, with some already in clinical trials.
Sputnik V is the third vaccine India has given the go-ahead to after 'Covishield', developed by Oxford University and AstraZeneca and 'Covaxin', the indigenous vaccine manufactured by Bharat Biotech. Covishield is manufactured by the Serum Institute of India.
The health ID will contain information about medical data, prescriptions and diagnostic reports and summaries of previous discharge from hospitals for ailments. The mission is expected to bring efficiency and transparency in healthcare services in the country.
'Modi forgot to ask Trump for anything that India may need -- and there is so much shortfall all around!', states Ambassador M K Bhadrakumar.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances